Laser catheter shows promise for unclogging leg arteries
NCT ID NCT04229563
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how well the AURYON atherectomy device works for people with peripheral artery disease (PAD), where leg arteries become blocked. The device uses a laser to vaporize plaque and restore blood flow. Researchers followed 102 patients to see if the procedure was safe and effective right after treatment and over time. The goal was to see if the device could clear blockages with few complications.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
AURYON Atherectomy System (a laser catheter device)
What this could lead to
If successful, this device could offer a safe and effective way to clear blockages in leg arteries, improving blood flow and reducing symptoms like pain or wounds.
What could go wrong
This is a small, single-arm registry (102 people) with no comparison group, so results may not apply to everyone. Risks include vessel damage, blood clots, or need for further procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Amavita Clinical Research
Miami, Florida, 33169, United States
-
Comprehensive Cardiovascular
Davenport, Florida, 33837, United States
-
First Coast Cardiovascular Institute
Jacksonville, Florida, 32256, United States
-
Hurricane Cardiology
New Braunfels, Texas, 78130, United States
-
Medical City Heart and Spine
Dallas, Texas, 75243, United States
-
Midwest Cardio. research foundation
Davenport, Iowa, 52803, United States
-
NJ Endovascular Amputation Prevention
Clifton, New Jersey, 07013, United States
-
Pima Vascular
Tucson, Arizona, 85718, United States
-
Pulse Cardiovacular
Scottsdale, Arizona, 85259, United States
-
Rush University Medical Center
Chicago, Illinois, 60612, United States